News
Recent research highlights the potential of non-psychoactive cannabinoids—CBD, CBG, and CBN—as promising therapeutic tools for Autism Spectrum Disorder (ASD). CBD has shown efficacy in reducing anxiety, aggression, and sleep disturbances, while CBG may support cognitive function and reduce neuroinflammation. CBN, often associated with sleep improvement, is also being studied for its neurogenic properties. The most significant benefits appear when these compounds work together in full-spectrum formulations, leveraging the entourage effect to enhance symptom relief. While further large-scale studies are needed, these findings suggest that cannabinoids could play a transformative role in ASD treatment.
Whether you’re looking to reduce inflammation, improve your sleep, or give your gut a fighting chance, cannabinoids offer a natural and multi-faceted approach to managing Crohn’s disease.
Start low, go slow, and keep your healthcare provider in the loop. With the right blend of CBD, CBN, CBG, and full-spectrum formulations, you might just find the relief your gut has been craving. Why not let cannabinoids step up as your gut's new best friend?
The growing body of research on cannabigerol (CBG) reveals its immense potential as a therapeutic compound. With its anti-inflammatory, neuroprotective, antimicrobial, anticancer, and mood-stabilizing properties, CBG presents a promising avenue for the development of novel treatments for a wide range of health conditions.
